Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mepolizumab Effectiveness in Patients With Severe Eosinophilic Asthma and Co-presence of Bronchiectasis

NCT05189613 is registered in ClinicalTrials.gov with Policlinico Universitario, Catania as lead sponsor.

NCT NCT05189613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05189613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mepolizumab Effectiveness in Patients With Severe Eosinophilic Asthma and Co-presence of Bronchiectasis
Lead sponsor
Policlinico Universitario, Catania
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2021
Completion date
December 31, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchial asthma, bronchiectasis